Treatment of epilepsy in mentally retarded patients with a slow‐release carbamazine preparation

Journal of Intellectual Disability Research

Volumn 35, Issue 3, 1991, Pages 231-239

  KASKI, M ^a   HEINONEN, E ^b   SIVENIUS, J ^c   TUOMINEN, J ^b   ANTTILA, M ^b  

^a Research Center ^*  (Finland)

^b ORION CORPORATION   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIPLOPIA; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG THERAPY; EPILEPSY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MENTAL DEFICIENCY; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION;

ADOLESCENT; ADULT; CARBAMAZEPINE; CHILD; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVOKED POTENTIALS; FEMALE; HUMAN; MALE; MENTAL RETARDATION;

EID: 0025818057     PISSN: 09642633     EISSN: 13652788     Source Type: Journal    
DOI: 10.1111/j.1365-2788.1991.tb01056.x     Document Type: Article

References (15)

1. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine‐10,11‐epoxide
2. Plasma levels of carbamazepine and carbamazepine‐10,11‐epoxide during treatment of epilepsy
3. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy
4. Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects
5. Comparison of serum concentration profiles of Tegretol and two new slow‐release preparations
6. Systematic comparison of three basic methods of sample pretreatment for high‐performance liquid chromatographic analysis of antiepileptic drugs using gas chromatography as a reference method
7. Carbamazepine retard in der Epilepsietherapie
8. Drug compliance and seizure control in epileptic children
9. Carbamazepine side effects in children and adults
10. Differences in side effects between a conventional carbamazepine preparation and a slow release preparation of carbamazepine
11. Multiple‐dose pharmacokinetic study with a slow‐release carbamazepine preparation
12. Monotherapy for epilepsy
13. Reduction of dosing frequency of carbamazepine with a slow‐release preparation
14. Results of a nationwide veterans administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin and primidone
15. Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects